Lilly’s diabetes drug better than Sanofi’s in late-stage trials

[Reuters] – * Drug lowers blood sugar levels in 3 late-stage trials * Lilly’s shares flat in late morning trading (Adds details, background, stock movement) May 12 (Reuters) – Eli Lilly and Co said its type 2 diabetes drug was more effective than Sanofi more

View todays social media effects on LLY

View the latest stocks trending across Twitter. Click to view dashboard

See who Eli is hiring next, click here to view